ACTIVE

Apotheek Popelier

Export PDF

Financial year 2025 · closed on 30/09/2025

Net result

61,9 k €

-3.5% YoY

Gross margin

170,9 k €

+3.6% YoY

Equity

521,8 k €

+0.2% YoY

Workforce

0,0 ETP

What does Apotheek Popelier do?

Apotheek Popelier is a Private limited company incorporated in 1990. Its registered office is in Brugge.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0441.997.821

Incorporation

09/11/1990

Legal form

Private limited company

Registered office

Dorpsstraat 4a
8200 Brugge · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

30/09/2025

Average workforce

0,0 ETP

Joint committees (2)

313
31300

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2025		2024		2023		2022		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	170,9 k €	+3.6%	165 k €	+29.4%	127,5 k €	-28.5%	178,3 k €	+105%	87,2 k €	-24.8%	116 k €	+10.4%	105 k €	+16.4%	90,2 k €	-31.6%	131,8 k €	-0.8%	132,9 k €	-20.2%	166,5 k €	+21.5%	137 k €	-18.9%	169 k €	+14.9%	147,1 k €	+11.9%	131,4 k €	+20.0%	109,5 k €
EBITDA	95,9 k €	+0.6%	95,4 k €	+58.0%	60,3 k €	-49.0%	118,4 k €	+148%	47,8 k €	-39.0%	78,3 k €	+11.1%	70,5 k €	-5.2%	74,4 k €	-27.3%	102,2 k €	-1.4%	103,7 k €	-27.5%	143,1 k €	+28.2%	111,6 k €	-20.1%	139,7 k €	+9.0%	128,2 k €	+48.1%	86,5 k €	+73.0%	50 k €
Operating result	64,4 k €	-2.9%	66,4 k €	+110%	31,5 k €	-64.1%	87,9 k €	+3461%	2,5 k €	-91.3%	28,3 k €	+78.0%	15,9 k €	+18.9%	13,4 k €	-73.6%	50,7 k €	-35.4%	78,4 k €	-33.6%	118,1 k €	+36.6%	86,4 k €	-24.7%	114,8 k €	-1.3%	116,3 k €	+472%	20,3 k €	-55.7%	45,9 k €
Net result	61,9 k €	-3.5%	64,2 k €	+103%	31,6 k €	-62.0%	83,2 k €	+3170%	-2,7 k €	-115%	18,6 k €	+79.7%	10,4 k €	+18.2%	8,8 k €	-79.1%	42,1 k €	-24.0%	55,3 k €	+0.1%	55,3 k €	+0.6%	54,9 k €	-25.2%	73,4 k €	-4.0%	76,5 k €	+166%	28,8 k €	-38.3%	46,7 k €
Balance sheet
Equity	521,8 k €	+0.2%	520,9 k €	+0.3%	519,2 k €	+0.3%	517,5 k €	+16.5%	444,1 k €	-50.5%	896,8 k €	+2.1%	878,2 k €	+0.9%	870,2 k €	+0.7%	863,9 k €	-1.2%	874,2 k €	+6.8%	818,9 k €	+6.9%	766 k €	+7.7%	711,1 k €	+11.1%	640 k €	+13.1%	565,9 k €	+4.9%	539,5 k €
Total assets	784,2 k €	-1.1%	793,2 k €	+5.0%	755,4 k €	+2.9%	733,8 k €	-38.5%	1,2 M €	-2.7%	1,2 M €	-1.7%	1,2 M €	-2.3%	1,3 M €	-2.6%	1,3 M €	+18.2%	1,1 M €	-7.0%	1,2 M €	-5.6%	1,3 M €	+4.4%	1,2 M €	+5.8%	1,1 M €	+7.5%	1,1 M €	+75.4%	606,8 k €
Cash	87,3 k €	+4.7%	83,3 k €	+4.6%	79,7 k €	-21.4%	101,4 k €	-46.3%	188,8 k €	-5.0%	198,8 k €	+24.4%	159,8 k €	+51.1%	105,7 k €	-50.6%	214,2 k €	+23.1%	174,1 k €	-35.0%	267,9 k €	+21.4%	220,7 k €	+65.2%	133,6 k €	-27.5%	184,2 k €	+370%	39,2 k €	-67.3%	119,6 k €
Debts	261,1 k €	-3.7%	271,1 k €	+15.0%	235,8 k €	+9.4%	215,5 k €	-70.3%	724,6 k €	+121%	327,8 k €	-11.2%	369 k €	-9.1%	405,9 k €	-9.1%	446,4 k €	+90.7%	234,1 k €	-36.9%	370,7 k €	-25.2%	495,7 k €	-0.3%	497,3 k €	-1.0%	502,1 k €	+1.5%	494,6 k €	+635%	67,3 k €
Other
Workforce	0,0 ETP		0,0 ETP	-100%	1,0 ETP		–		0,6 ETP	0.0%	0,6 ETP	+20.0%	0,5 ETP	+400%	0,1 ETP	-87.5%	0,8 ETP	+33.3%	0,6 ETP	+20.0%	0,5 ETP	-16.7%	0,6 ETP	0.0%	0,6 ETP	+20.0%	0,5 ETP	-54.5%	1,1 ETP	-35.3%	1,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2025 · 2 active · 13 ended

Active mandates

REBA PHARMA

Director · 0778.952.857

Represented by Popelier BIEKE

Active

VEMAPHAR

Director · 0471.640.427

Represented by Verbeke KOEN

Active

Ended mandates

REBA PHARMA

Director · since 01 mars 2022 · 0778.952.857

Represented by Bieke POPELIER

Ended

VEMAPHAR

Director · since 01 mars 2022 · 0471.640.427

Represented by Koen VERBEKE

Ended

Mady Van Der Linden

Director · since 11 mai 2010 · until 28 février 2022

Ended

Mady Van Der Linden

Director · since 11 mai 2010 · until 01 mars 2022

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/10/2024	01/10/2023	01/10/2022	01/10/2021	01/10/2020	01/10/2019
Closing of the financial year	30/09/2025	30/09/2024	30/09/2023	30/09/2022	30/09/2021	30/09/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/04/2026	09/04/2025	03/04/2024	29/03/2023	16/03/2022	29/03/2021
General meeting	13/03/2026	14/03/2025	10/03/2024	10/03/2023	28/02/2022	12/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/09/2025	13/03/2026	02/04/2026	Dutch	PDF
Abridged model	30/09/2024	14/03/2025	09/04/2025	Dutch	PDF
Abridged model	30/09/2023	10/03/2024	03/04/2024	Dutch	PDF
Abridged model	30/09/2022	10/03/2023	29/03/2023	Dutch	PDF
Abridged model	30/09/2021	28/02/2022	16/03/2022	Dutch	PDF
Abridged model	30/09/2020	12/03/2021	29/03/2021	Dutch	PDF
Abridged model	30/09/2019	13/03/2020	25/03/2020	Dutch	PDF
Abridged model	30/09/2018	08/03/2019	03/04/2019	Dutch	PDF
Abridged model	30/09/2017	09/03/2018	09/04/2018	Dutch	PDF
Abridged model	30/09/2016	10/03/2017	21/04/2017	Dutch	PDF
Abridged model	30/09/2015	11/03/2016	29/03/2016	Dutch	PDF
Abridged model	30/09/2014	13/03/2015	03/04/2015	Dutch	PDF
Abridged model	30/09/2013	14/03/2014	10/04/2014	Dutch	PDF
Abridged model	30/09/2012	05/04/2013	30/04/2013	Dutch	PDF
Abridged model	30/09/2011	30/03/2012	24/04/2012	Dutch	PDF
Abridged model	30/09/2010	11/03/2011	04/04/2011	Dutch	PDF
Abridged model	30/09/2009	12/03/2010	02/04/2010	Dutch	PDF
Abridged model	30/09/2008	13/03/2009	25/03/2009	Dutch	PDF
Abridged model	30/09/2007	14/03/2008	31/03/2008	Dutch	PDF
Abridged model	30/09/2006	09/03/2007	16/03/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 2 active · 13 ended

Active mandates

REBA PHARMA

Director · 0778.952.857

Represented by Popelier BIEKE

Active

VEMAPHAR

Director · 0471.640.427

Represented by Verbeke KOEN

Active

Ended mandates

REBA PHARMA

Director · since 01 mars 2022 · 0778.952.857

Represented by Bieke POPELIER

Ended

VEMAPHAR

Director · since 01 mars 2022 · 0471.640.427

Represented by Koen VERBEKE

Ended

Mady Van Der Linden

Director · since 11 mai 2010 · until 28 février 2022

Ended

Mady Van Der Linden

Director · since 11 mai 2010 · until 01 mars 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates14/03/2022
WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Capital / shares12/07/2018
KAPITAAL - AANDELEN
PDF
Capital / shares15/07/2014
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates15/07/2010
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202561,9 k €↓
2024
Annual accounts 202464,2 k €↑
2023
Annual accounts 202331,6 k €↓
2022
Annual accounts 202283,2 k €↑
2018
Annual accounts 2018-2,7 k €↓
2017
Annual accounts 201718,6 k €↑
2016
Annual accounts 201610,4 k €↑
2015
Annual accounts 20158,8 k €↓
2014
Annual accounts 201442,1 k €↓
2013
Annual accounts 201355,3 k €↑
2012
Annual accounts 201255,3 k €↑
2011
Annual accounts 201154,9 k €↓
2010
Annual accounts 201073,4 k €↓
2009
Annual accounts 200976,5 k €↑
2008
Annual accounts 200828,8 k €↓
2007
Annual accounts 200746,7 k €
09/11/1990
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Apotheek Popelier

Overview

What does Apotheek Popelier do?

Trend over 16 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline